PLDT Inc. Sponsored ADR (PHI)

Short-Term Debt

₱41.20B

Quarterly · Period ending: · PHP

PHI logo

PHI Short-Term Debt

Latest reported₱41.20B PHP
PHI Quarterly Short-Term Debt · PHP (₱3.18B → ₱41.20B)
High-resolution chart · PNG

PHI short-term debt history

Quarterly · PHP. Dates are reporting period ends; fiscal years can differ from calendar years.

PLDT Inc. Sponsored ADR Short-Term Debt — Quarterly (PHP)
Period endingShort-Term Debt (PHP)
41,201,117,000
38,407,754,000
25,064,426,000
26,073,000,000
30,398,000,000
27,749,000,000
30,675,000,000
26,205,000,000
18,382,000,000
17,297,000,000
17,567,000,000
40,465,000,000
43,696,000,000
43,312,000,000
42,769,000,000
33,113,000,000
21,239,000,000
18,865,000,000
16,037,000,000
14,956,000,000
11,600,000,000
9,537,000,000
21,613,000,000
29,202,000,000
39,141,000,000
42,920,000,000
22,937,000,000
21,616,000,000
19,793,000,000
25,448,000,000
20,441,000,000
14,258,000,000
10,950,000,000
11,840,000,000
14,957,000,000
15,625,000,000
14,826,000,000
18,001,000,000
33,273,000,000
32,761,000,000
29,266,000,000
30,217,000,000
16,911,000,000
16,957,000,000
16,747,000,000
15,623,000,000
14,729,000,000
14,779,000,000
14,031,000,000
14,122,000,000
15,171,000,000
14,258,000,000
30,639,000,000
12,004,000,000
12,989,000,000
21,895,000,000
13,935,000,000
21,340,000,000
26,009,000,000
20,538,000,000
22,449,000,000
14,167,000,000
13,801,000,000
12,720,000,000
11,148,000,000
13,158,000,000
12,714,000,000
13,476,000,000
13,044,000,000
15,887,000,000
-15,222,424,550
15,315,528,600
15,261,008,800
8,856,548,520
8,751,290,040
9,431,081,100
9,025,811,760
11,173,291,320
21,782,662,300
20,520,520,500
19,179,684,520
24,547,406,400
18,984,994,180
21,234,873,510
29,355,742,840
23,506,849,080
26,797,755,060
31,516,856,580
22,352,941,590
27,808,991,100
25,944,446,520
23,588,024,148
23,449,039,262
19,968,985,514
20,053,477,500
20,853,701,454
35,452,591,817
26,519,480,802
25,747,627,990
25,853,006,833
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.